APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Banking and Blood Products

Blood banking includes typing the blood for transfusion and testing for infectious diseases. A blood product is any therapeutic substance prepared from human blood.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Blood banking includes typing the blood for transfusion and testing for infectious diseases. A blood product is any therapeutic substance prepared from human blood.

Selected research

Market Outlook & Growth Opportunities

Global Blood Banking and Blood Products Market Outlook and Growth Opportunities 2026

20 December 2025197 pages

Choose your research edition.

Industry ResearchBlood Banking and Blood Products Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Banking and Blood Products Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Blood Banking and Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Banking and Blood Products Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Banking and Blood Products Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Blood banking includes typing the blood for transfusion and testing for infectious diseases. A blood product is any therapeutic substance prepared from human blood.

America’s Blood Centers was the global greatest company in Marine Blood Banking and Blood Products industry, with the market Share of 9% , followed by Japan Red Cross Society, American Red Cross, Australia Red Cross, Red Cross Society of China, NHS Blood and Transplant, New York Blood Center, Canadian Blood Services, Sanquin Blood Supply Foundation.Europe is the largest Blood Banking and Blood Products market with about 36% market share. North America is follower, accounting for about 33% market share.

This report provides an overview of the global Blood Banking and Blood Products market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Blood Banking and Blood Products and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Banking and Blood Products revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Blood Banking and Blood Products market.

Blood Banking and Blood Products Segment by Company

America’s Blood Centers

Japan Red Cross Society

American Red Cross

Australia Red Cross

Red Cross Society of China

NHS Blood and Transplant

New York Blood Center

Canadian Blood Services

Sanquin Blood Supply Foundation

Blood Banking and Blood Products Segment by Type

RBCs

Plts

Plasma

Cryo

Whole Blood

Blood Banking and Blood Products Segment by Application

Trauma & Surgery

Cancer Treatment

Bleeding Disorder

Others

Blood Banking and Blood Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Blood Banking and Blood Products status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Blood Banking and Blood Products key companies, revenue, market share, and recent developments.

3. To split the Blood Banking and Blood Products breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Blood Banking and Blood Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Blood Banking and Blood Products significant trends, drivers, influence factors in global and regions.

6. To analyze Blood Banking and Blood Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Banking and Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Banking and Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Banking and Blood Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Banking and Blood Products industry.

Chapter 3: Detailed analysis of Blood Banking and Blood Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Blood Banking and Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Blood Banking and Blood Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Blood Banking and Blood Products Industry Trends Table 2. Blood Banking and Blood Products Industry Drivers Table 3. Blood Banking and Blood Products Industry Opportunities and Challenges Table 4. Blood Banking and Blood Products Industry Restraints Table 5. Global Blood Banking and Blood Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Blood Banking and Blood Products Revenue Share by Company (2021-2026) Table 7. Global Blood Banking and Blood Products Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Blood Banking and Blood Products Key Company Manufacturing Base & Headquarters Table 9. Global Blood Banking and Blood Products Company, Product Type & Application Table 10. Global Blood Banking and Blood Products Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Blood Banking and Blood Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of RBCs Table 15. Significant Companies of Plts Table 16. Significant Companies of Plasma Table 17. Significant Companies of Cryo Table 18. Significant Companies of Whole Blood Table 19. Global Blood Banking and Blood Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Blood Banking and Blood Products Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Blood Banking and Blood Products Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Blood Banking and Blood Products Sales Value Share by Type (2021-2026) Table 23. Global Blood Banking and Blood Products Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Trauma & Surgery Table 25. Significant Companies of Cancer Treatment Table 26. Significant Companies of Bleeding Disorder Table 27. Significant Companies of Others Table 28. Global Blood Banking and Blood Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Blood Banking and Blood Products Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Blood Banking and Blood Products Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Blood Banking and Blood Products Sales Value Share by Application (2021-2026) Table 32. Global Blood Banking and Blood Products Sales Value Share by Application (2027-2032) Table 33. Global Blood Banking and Blood Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Blood Banking and Blood Products Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Blood Banking and Blood Products Sales Value Share by Region (2021-2026) Table 36. Global Blood Banking and Blood Products Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Blood Banking and Blood Products Sales Value Share by Region (2027-2032) Table 38. Global Blood Banking and Blood Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Blood Banking and Blood Products Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Blood Banking and Blood Products Sales Value Market Share by Country (2021-2026) Table 41. Global Blood Banking and Blood Products Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Blood Banking and Blood Products Sales Value Market Share by Country (2027-2032) Table 43. America’s Blood Centers Company Information Table 44. America’s Blood Centers Business Overview Table 45. America’s Blood Centers Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. America’s Blood Centers Blood Banking and Blood Products Product Portfolio Table 47. America’s Blood Centers Recent Development Table 48. Japan Red Cross Society Company Information Table 49. Japan Red Cross Society Business Overview Table 50. Japan Red Cross Society Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Japan Red Cross Society Blood Banking and Blood Products Product Portfolio Table 52. Japan Red Cross Society Recent Development Table 53. American Red Cross Company Information Table 54. American Red Cross Business Overview Table 55. American Red Cross Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. American Red Cross Blood Banking and Blood Products Product Portfolio Table 57. American Red Cross Recent Development Table 58. Australia Red Cross Company Information Table 59. Australia Red Cross Business Overview Table 60. Australia Red Cross Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Australia Red Cross Blood Banking and Blood Products Product Portfolio Table 62. Australia Red Cross Recent Development Table 63. Red Cross Society of China Company Information Table 64. Red Cross Society of China Business Overview Table 65. Red Cross Society of China Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Red Cross Society of China Blood Banking and Blood Products Product Portfolio Table 67. Red Cross Society of China Recent Development Table 68. NHS Blood and Transplant Company Information Table 69. NHS Blood and Transplant Business Overview Table 70. NHS Blood and Transplant Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. NHS Blood and Transplant Blood Banking and Blood Products Product Portfolio Table 72. NHS Blood and Transplant Recent Development Table 73. New York Blood Center Company Information Table 74. New York Blood Center Business Overview Table 75. New York Blood Center Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. New York Blood Center Blood Banking and Blood Products Product Portfolio Table 77. New York Blood Center Recent Development Table 78. Canadian Blood Services Company Information Table 79. Canadian Blood Services Business Overview Table 80. Canadian Blood Services Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Canadian Blood Services Blood Banking and Blood Products Product Portfolio Table 82. Canadian Blood Services Recent Development Table 83. Sanquin Blood Supply Foundation Company Information Table 84. Sanquin Blood Supply Foundation Business Overview Table 85. Sanquin Blood Supply Foundation Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sanquin Blood Supply Foundation Blood Banking and Blood Products Product Portfolio Table 87. Sanquin Blood Supply Foundation Recent Development Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Blood Banking and Blood Products Product Image Figure 2. Global Blood Banking and Blood Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood Banking and Blood Products Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. RBCs Image Figure 8. Plts Image Figure 9. Plasma Image Figure 10. Cryo Image Figure 11. Whole Blood Image Figure 12. Global Blood Banking and Blood Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Blood Banking and Blood Products Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Blood Banking and Blood Products Sales Value Share by Type (2021-2032) Figure 15. Trauma & Surgery Image Figure 16. Cancer Treatment Image Figure 17. Bleeding Disorder Image Figure 18. Others Image Figure 19. Global Blood Banking and Blood Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Blood Banking and Blood Products Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Blood Banking and Blood Products Sales Value Share by Application (2021-2032) Figure 22. Global Blood Banking and Blood Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Blood Banking and Blood Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Blood Banking and Blood Products Sales Value (2021-2032) & (US$ Million) Figure 25. North America Blood Banking and Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Blood Banking and Blood Products Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Blood Banking and Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Blood Banking and Blood Products Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Blood Banking and Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Blood Banking and Blood Products Sales Value (2021-2032) & (US$ Million) Figure 31. South America Blood Banking and Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Blood Banking and Blood Products Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Blood Banking and Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • RBCs
  • Plts
  • Plasma
  • Cryo
  • Whole Blood
Applications
  • Trauma & Surgery
  • Cancer Treatment
  • Bleeding Disorder
  • Others
Companies covered
  • America’s Blood Centers
  • Japan Red Cross Society
  • American Red Cross
  • Australia Red Cross
  • Red Cross Society of China
  • NHS Blood and Transplant
  • New York Blood Center
  • Canadian Blood Services
  • Sanquin Blood Supply Foundation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Blood Banking and Blood Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Blood Banking and Blood Products Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Blood Banking and Blood Products Market Dynamics
  1. 2.1 Blood Banking and Blood Products Industry Trends
  2. 2.2 Blood Banking and Blood Products Industry Drivers
  3. 2.3 Blood Banking and Blood Products Industry Opportunities and Challenges
  4. 2.4 Blood Banking and Blood Products Industry Restraints
3 Blood Banking and Blood Products Market by Company
  1. 3.1 Global Blood Banking and Blood Products Company Revenue Ranking in 2025
  2. 3.2 Global Blood Banking and Blood Products Revenue by Company (2021-2026)
  3. 3.3 Global Blood Banking and Blood Products Company Ranking (2024-2026)
  4. 3.4 Global Blood Banking and Blood Products Company Manufacturing Base and Headquarters
  5. 3.5 Global Blood Banking and Blood Products Company Product Type and Application
  6. 3.6 Global Blood Banking and Blood Products Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Blood Banking and Blood Products Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Blood Banking and Blood Products Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Blood Banking and Blood Products Market by Type
  1. 4.1 Blood Banking and Blood Products Type Introduction
  2. 4.1.1 RBCs
  3. 4.1.2 Plts
  4. 4.1.3 Plasma
  5. 4.1.4 Cryo
  6. 4.1.5 Whole Blood
  7. 4.2 Global Blood Banking and Blood Products Sales Value by Type
  8. 4.2.1 Global Blood Banking and Blood Products Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Blood Banking and Blood Products Sales Value by Type (2021-2032)
  10. 4.2.3 Global Blood Banking and Blood Products Sales Value Share by Type (2021-2032)
5 Blood Banking and Blood Products Market by Application
  1. 5.1 Blood Banking and Blood Products Application Introduction
  2. 5.1.1 Trauma & Surgery
  3. 5.1.2 Cancer Treatment
  4. 5.1.3 Bleeding Disorder
  5. 5.1.4 Others
  6. 5.2 Global Blood Banking and Blood Products Sales Value by Application
  7. 5.2.1 Global Blood Banking and Blood Products Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Blood Banking and Blood Products Sales Value by Application (2021-2032)
  9. 5.2.3 Global Blood Banking and Blood Products Sales Value Share by Application (2021-2032)
6 Blood Banking and Blood Products Regional Value Analysis
  1. 6.1 Global Blood Banking and Blood Products Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood Banking and Blood Products Sales Value by Region (2021-2032)
  3. 6.2.1 Global Blood Banking and Blood Products Sales Value by Region: 2021-2026
  4. 6.2.2 Global Blood Banking and Blood Products Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Blood Banking and Blood Products Sales Value (2021-2032)
  7. 6.3.2 North America Blood Banking and Blood Products Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Blood Banking and Blood Products Sales Value (2021-2032)
  10. 6.4.2 Europe Blood Banking and Blood Products Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Blood Banking and Blood Products Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Blood Banking and Blood Products Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Blood Banking and Blood Products Sales Value (2021-2032)
  16. 6.6.2 South America Blood Banking and Blood Products Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Blood Banking and Blood Products Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Blood Banking and Blood Products Sales Value Share by Country, 2025 VS 2032
7 Blood Banking and Blood Products Country-level Value Analysis
  1. 7.1 Global Blood Banking and Blood Products Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Blood Banking and Blood Products Sales Value by Country (2021-2032)
  3. 7.2.1 Global Blood Banking and Blood Products Sales Value by Country (2021-2026)
  4. 7.2.2 Global Blood Banking and Blood Products Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 America’s Blood Centers
  2. 8.1.1 America’s Blood Centers Company Information
  3. 8.1.2 America’s Blood Centers Business Overview
  4. 8.1.3 America’s Blood Centers Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  5. 8.1.4 America’s Blood Centers Blood Banking and Blood Products Product Portfolio
  6. 8.1.5 America’s Blood Centers Recent Developments
  7. 8.2 Japan Red Cross Society
  8. 8.2.1 Japan Red Cross Society Company Information
  9. 8.2.2 Japan Red Cross Society Business Overview
  10. 8.2.3 Japan Red Cross Society Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Japan Red Cross Society Blood Banking and Blood Products Product Portfolio
  12. 8.2.5 Japan Red Cross Society Recent Developments
  13. 8.3 American Red Cross
  14. 8.3.1 American Red Cross Company Information
  15. 8.3.2 American Red Cross Business Overview
  16. 8.3.3 American Red Cross Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  17. 8.3.4 American Red Cross Blood Banking and Blood Products Product Portfolio
  18. 8.3.5 American Red Cross Recent Developments
  19. 8.4 Australia Red Cross
  20. 8.4.1 Australia Red Cross Company Information
  21. 8.4.2 Australia Red Cross Business Overview
  22. 8.4.3 Australia Red Cross Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Australia Red Cross Blood Banking and Blood Products Product Portfolio
  24. 8.4.5 Australia Red Cross Recent Developments
  25. 8.5 Red Cross Society of China
  26. 8.5.1 Red Cross Society of China Company Information
  27. 8.5.2 Red Cross Society of China Business Overview
  28. 8.5.3 Red Cross Society of China Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Red Cross Society of China Blood Banking and Blood Products Product Portfolio
  30. 8.5.5 Red Cross Society of China Recent Developments
  31. 8.6 NHS Blood and Transplant
  32. 8.6.1 NHS Blood and Transplant Company Information
  33. 8.6.2 NHS Blood and Transplant Business Overview
  34. 8.6.3 NHS Blood and Transplant Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NHS Blood and Transplant Blood Banking and Blood Products Product Portfolio
  36. 8.6.5 NHS Blood and Transplant Recent Developments
  37. 8.7 New York Blood Center
  38. 8.7.1 New York Blood Center Company Information
  39. 8.7.2 New York Blood Center Business Overview
  40. 8.7.3 New York Blood Center Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  41. 8.7.4 New York Blood Center Blood Banking and Blood Products Product Portfolio
  42. 8.7.5 New York Blood Center Recent Developments
  43. 8.8 Canadian Blood Services
  44. 8.8.1 Canadian Blood Services Company Information
  45. 8.8.2 Canadian Blood Services Business Overview
  46. 8.8.3 Canadian Blood Services Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Canadian Blood Services Blood Banking and Blood Products Product Portfolio
  48. 8.8.5 Canadian Blood Services Recent Developments
  49. 8.9 Sanquin Blood Supply Foundation
  50. 8.9.1 Sanquin Blood Supply Foundation Company Information
  51. 8.9.2 Sanquin Blood Supply Foundation Business Overview
  52. 8.9.3 Sanquin Blood Supply Foundation Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sanquin Blood Supply Foundation Blood Banking and Blood Products Product Portfolio
  54. 8.9.5 Sanquin Blood Supply Foundation Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst